Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Non-Current Debt (2016 - 2022)

Avanos Medical's Non-Current Debt history spans 8 years, with the latest figure at $226.3 million for Q4 2022.

  • For Q4 2022, Non-Current Debt rose 74.08% year-over-year to $226.3 million; the TTM value through Dec 2022 reached $226.3 million, up 74.08%, while the annual FY2022 figure was $226.3 million, 74.08% up from the prior year.
  • Non-Current Debt for Q4 2022 was $226.3 million at Avanos Medical, up from $130.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $542.0 million in Q1 2018 and bottomed at $130.0 million in Q4 2021.
  • The 4-year median for Non-Current Debt is $247.6 million (2018), against an average of $273.6 million.
  • The largest annual shift saw Non-Current Debt plummeted 57.34% in 2018 before it skyrocketed 74.08% in 2022.
  • A 4-year view of Non-Current Debt shows it stood at $247.7 million in 2018, then rose by 0.08% to $247.9 million in 2019, then tumbled by 47.56% to $130.0 million in 2021, then surged by 74.08% to $226.3 million in 2022.
  • Per Business Quant, the three most recent readings for AVNS's Non-Current Debt are $226.3 million (Q4 2022), $130.0 million (Q4 2021), and $247.9 million (Q3 2019).